In this publication, we report the screening of several formats of antagonist anti-PDL1 sdAb as well as CD40 or 4-1BB agonist constructions that were tested in the context of tumor cells infected by an oncolytic vaccinia virus to select the most effective payloads for each pathway. Here, CD274 is linked to neoplasm.